サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1781302

神経バイオマーカーの免疫測定法の世界市場

Immunoassay for Neurological Biomarkers

出版日
ページ情報
英文 380 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
神経バイオマーカーの免疫測定法の世界市場
出版日: 2025年08月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 380 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

神経バイオマーカーの免疫測定法の世界市場は2030年までに21億米ドルに達する見込み

2024年に8億990万米ドルと推定される神経バイオマーカーの免疫測定法の世界市場は、分析期間2024-2030年にCAGR 17.3％で成長し、2030年には21億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである機器神経バイオマーカーの免疫測定法は、CAGR 19.4％を記録し、分析期間終了時には13億米ドルに達すると予測されています。試薬神経バイオマーカーの免疫測定法セグメントの分析期間中のCAGR成長率は14.2％と推定されます。

米国市場は2億2,060万米ドルと推定、中国はCAGR23.2％で成長予測

米国の神経バイオマーカーの免疫測定法市場は、2024年に2億2,060万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR23.2%で推移し、2030年までに4億7,490万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、それぞれ分析期間中に12.6%と15.7%のCAGRで成長すると予測されています。欧州では、ドイツがCAGR約13.8%で成長すると予測されています。

世界の神経バイオマーカーの免疫測定法市場- 神経診断学の進歩

神経学で免疫測定が重要になる理由

神経バイオマーカー用の免疫測定法は、アルツハイマー病、パーキンソン病、多発性硬化症などの神経変性疾患に関連するタンパク質を検出・定量できることから、大きな注目を集めています。これらの疾患の有病率の上昇と人口の高齢化が相まって、早期かつ正確な診断ツールの需要が高まっています。イムノアッセイは、血液や脳脊髄液中の神経バイオマーカーを検出する非侵襲的な方法を提供し、タイムリーな介入や疾患管理を可能にします。

免疫測定技術の革新は市場にどのような影響を与えているか？

高感度マルチプレックスイムノアッセイやデジタルイムノアッセイなどの技術の進歩により、神経学的診断の精度と拡張性が向上しています。AIを活用したデータ解析はバイオマーカー検出をさらに洗練させ、神経疾患の早期特定を可能にしています。さらに、ポイント・オブ・ケア免疫測定プラットフォームの開発により、神経診断がより身近なものとなり、専門的な検査インフラへの依存度が低下しています。また、定期的なモニタリングを必要とする患者のために、携帯型や家庭用の診断キットも登場しています。

市場の成長要因は何か？

神経変性疾患の早期診断への注目の高まり、バイオマーカー研究への投資の増加、製薬会社と診断会社の協力関係の高まりは、この市場の主な成長要因です。神経学研究を促進する政府の取り組みや個別化医療の進展も、神経学的バイオマーカー検出用イムノアッセイ・アプリケーションの急速な拡大に寄与しています。さらに、製薬業界は医薬品開発や臨床試験にイムノアッセイを活用し、その用途をさらに拡大しています。

市場の将来は？

有望な成長にもかかわらず、規制上のハードル、コストの障壁、バイオマーカーパネルの標準化などの課題に対処する必要があります。しかし、AI、自動化、次世代シーケンサーの統合が進むことで、これらのギャップを埋めることができると期待されています。精密医療への需要が高まる中、神経バイオマーカー用イムノアッセイは、神経診断と患者ケアの変革において極めて重要な役割を果たすと思われます。

セグメント

製品（装置神経バイオマーカーの免疫測定法,試薬神経バイオマーカーの免疫測定法,サービス神経バイオマーカーの免疫測定法）;疾患（アルツハイマー病、パーキンソン病、多発性硬化症、その他の疾患）;アプリケーション（体外診断アプリケーション、調査アプリケーション）

調査対象企業の例

  • Abbott Laboratories
  • ADx NeuroSciences NV
  • Banyan Biomarkers, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • C2N Diagnostics
  • EnCor Biotechnology Inc.
  • F. Hoffmann-La Roche Ltd
  • Fujirebio
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Nimble Therapeutics
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Quanterix Corporation
  • Quibim
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP31538

Global Immunoassay for Neurological Biomarkers Market to Reach US$2.1 Billion by 2030

The global market for Immunoassay for Neurological Biomarkers estimated at US$809.9 Million in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 17.3% over the analysis period 2024-2030. Instruments Immunoassay for Neurological Biomarkers, one of the segments analyzed in the report, is expected to record a 19.4% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Reagents Immunoassay for Neurological Biomarkers segment is estimated at 14.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$220.6 Million While China is Forecast to Grow at 23.2% CAGR

The Immunoassay for Neurological Biomarkers market in the U.S. is estimated at US$220.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$474.9 Million by the year 2030 trailing a CAGR of 23.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.6% and 15.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR.

Global Immunoassay for Neurological Biomarkers Market - Advancing Neurodiagnostics

Why Are Immunoassays Becoming Crucial in Neurology?

Immunoassays for neurological biomarkers are gaining significant traction due to their ability to detect and quantify proteins associated with neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. The rising prevalence of these conditions, coupled with an aging population, has driven demand for early and accurate diagnostic tools. Immunoassays provide a non-invasive method for detecting neurological biomarkers in blood and cerebrospinal fluid, enabling timely intervention and disease management.

How Are Innovations in Immunoassay Technology Impacting the Market?

Technological advancements, including highly sensitive multiplex immunoassays and digital immunoassays, have improved the precision and scalability of neurological diagnostics. AI-driven data analysis is further refining biomarker detection, allowing for early-stage identification of neurological disorders. Moreover, the development of point-of-care immunoassay platforms is making neurodiagnostics more accessible, reducing dependency on specialized laboratory infrastructure. Portable and home-based diagnostic kits are also emerging, catering to patients who require regular monitoring.

What Are the Market Growth Factors?

The growing focus on early diagnosis of neurodegenerative diseases, increasing investment in biomarker research, and rising collaborations between pharmaceutical and diagnostic companies are major growth drivers in this market. Government initiatives promoting neurological research and advancements in personalized medicine are also contributing to the rapid expansion of immunoassay applications for neurological biomarker detection. Additionally, the pharmaceutical industry is leveraging immunoassays for drug development and clinical trials, further expanding their application.

What Lies Ahead for the Market?

Despite the promising growth, challenges such as regulatory hurdles, cost barriers, and standardization of biomarker panels need to be addressed. However, the increasing integration of AI, automation, and next-generation sequencing is expected to bridge these gaps. As demand for precision medicine grows, immunoassays for neurological biomarkers will play a pivotal role in transforming neurodiagnostics and patient care.

SCOPE OF STUDY:

The report analyzes the Immunoassay for Neurological Biomarkers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers, Services Immunoassay for Neurological Biomarkers); Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease, Other Diseases); Application (In Vitro Diagnostics Application, Research Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • ADx NeuroSciences NV
  • Banyan Biomarkers, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • C2N Diagnostics
  • EnCor Biotechnology Inc.
  • F. Hoffmann-La Roche Ltd
  • Fujirebio
  • Johnson & Johnson Services, Inc.
  • Merck KGaA
  • Nimble Therapeutics
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Quanterix Corporation
  • Quibim
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Immunoassay for Neurological Biomarkers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Burden of Neurodegenerative Disorders Spurs Demand for Early Diagnostic Immunoassays
    • Advances in Biomarker Discovery and Validation Propel Growth in Precision Neurology Diagnostics
    • Increased Focus on Alzheimers and Parkinsons Disease Detection Strengthens Business Case for Biomarker-Based Assays
    • Integration of Immunoassays into Routine Neurology Workflows Expands Clinical Adoption
    • Technological Innovation in Multiplex Platforms Enhances Sensitivity and Reduces Testing Time
    • Expansion of Companion Diagnostics in Neurology Fuels Demand for Target-Specific Immunoassays
    • Rising Investments in Neuroinflammation Research Throw Spotlight on Emerging Biomarker Panels
    • Shift Toward Blood-Based Diagnostics Propels Accessibility and Non-Invasive Testing Uptake
    • Accelerated FDA Approvals of Neurological Assays Drive Market Entry and Product Development
    • Academic-Industry Collaborations Boost Biomarker Validation and Translational Research
    • Growing Application of Immunoassays in Clinical Trials Drives Longitudinal Biomarker Monitoring
    • Biopharma Partnerships for Targeted Drug Development Drive Co-Development of Diagnostic Assays
    • Wearable Integration and Remote Monitoring Trends Support Point-of-Care Testing for Neurological Biomarkers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Immunoassay for Neurological Biomarkers Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Immunoassay for Neurological Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Immunoassay for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments Immunoassay for Neurological Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Instruments Immunoassay for Neurological Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Instruments Immunoassay for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Reagents Immunoassay for Neurological Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Reagents Immunoassay for Neurological Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Reagents Immunoassay for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services Immunoassay for Neurological Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services Immunoassay for Neurological Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Services Immunoassay for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Alzheimer's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Alzheimer's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Alzheimer's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Multiple Sclerosis Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Multiple Sclerosis Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Multiple Sclerosis Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for In Vitro Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for In Vitro Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for In Vitro Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • JAPAN
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • CHINA
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • EUROPE
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Immunoassay for Neurological Biomarkers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Immunoassay for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • FRANCE
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • GERMANY
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Immunoassay for Neurological Biomarkers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Immunoassay for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • INDIA
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Immunoassay for Neurological Biomarkers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Immunoassay for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Immunoassay for Neurological Biomarkers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Immunoassay for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030
  • AFRICA
    • Immunoassay for Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Immunoassay for Neurological Biomarkers by Product - Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Immunoassay for Neurological Biomarkers by Product - Percentage Breakdown of Value Sales for Instruments Immunoassay for Neurological Biomarkers, Reagents Immunoassay for Neurological Biomarkers and Services Immunoassay for Neurological Biomarkers for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Immunoassay for Neurological Biomarkers by Disease - Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Immunoassay for Neurological Biomarkers by Disease - Percentage Breakdown of Value Sales for Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis Disease and Other Diseases for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Immunoassay for Neurological Biomarkers by Application - In Vitro Diagnostics Application and Research Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Immunoassay for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for In Vitro Diagnostics Application and Research Application for the Years 2015, 2025 & 2030

IV. COMPETITION